https://www.live-feeds.com/feed/the-mystery-of-moderna-s-magic-algorithmContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/the-mystery-of-moderna-s-magic-algorithmhttps://www.live-feeds.com/feed/the-mystery-of-moderna-s-magic-algorithm#u51181Sat, 29 Aug 2026 01:56:13 +0000Moderna and Merck have developed a cancer vaccine designed to prevent the recurrence of melanoma. The treatment uses a personalized approach to trigger an immune response against cancer cells. While early trial results suggest the vaccine could revolutionize treatment and keep melanoma from returning, some analysts argue that the excitement surrounding the project exceeds the current mathematical evidence. The partnership represents a significant strategic bet for Moderna as it seeks to expand its mRNA platform beyond infectious diseases.Why it mattersmRNA technology allows for the creation of